Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pfizer And UCSF Expand Alliance

by Lisa M. Jarvis
June 3, 2013 | A version of this story appeared in Volume 91, Issue 22

Pfizer is expanding the scope of its drug development agreement with the University of California, San Francisco, to include small-molecule drug candidates. UCSF was the first partner in Pfizer’s academic network, called Centers for Therapeutic Innovation, launched in 2010 as a way for Pfizer scientists to work alongside academic researchers on novel biologics. Pfizer subsequently created CTI hubs in New York City, Boston, and San Diego. A call for proposals for the new small-molecule effort at UCSF is already under way. Meanwhile, Pfizer expects to launch other small-molecule projects through CTI later this year.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.